Abstract
Abstract
Institutional Development Awards for Clinical and Translational Research (IDeA-CTR) networks, funded by NIH/NIGMS, aim to advance CTR infrastructure to address historically unmet state and regional health needs. Success depends on the response to actionable feedback to IDeA-CTR leadership from network partners and governance groups through annual surveys, interviews, and governance body recommendations. The Great Plains IDeA-CTR applied internal formative meta-evaluation to evaluate dispositions of 172 governance recommendations from 2017 to 2021. Results provided insights to improve the classification and quality of recommendations, credibility of evaluation processes, responsiveness to recommendations, and communications and governance in a complex CTR network comprising multiple coalitions.
Publisher
Cambridge University Press (CUP)
Reference16 articles.
1. Responsive meta-evaluation: a participatory approach to enhancing evaluation quality;Sturges;Am J Eval,2017
2. Meta-evaluation;Stufflebeam;J Multidiscip Eval,2010
3. Metaevaluation in practice: selection and application of criteria;Cooksy;J MultiDiscip Eval,2009
4. 1. National Institutes of Health: National Institute of General Medical Sciences. Institutional Development Award (IDeA) Networks for Clinical and Translational Research (IDeA-CTR) (U54 Clinical Trial Optional). PAR-20-175: IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) (nih.gov). Accessed July 5, 2023.